원격의료 시장 : 시장 규모, 점유율, 동향 분석(제품 유형별, 제공 방식별, 질환 영역별, 최종 용도별, 지역별), 부문별 예측(2026-2033년)

Telehealth Market Summary

The global telehealth market size was valued at USD 77.4 billion in 2025 and is projected to grow from USD 87.7 billion in 2026 to USD 187.5 billion by 2033, at a CAGR of 11.5% from 2026 to 2033. North America dominated the telehealth market with the largest revenue share of 45.2% in 2025. The market is primarily driven by the increasing adoption of digital health & smartphones, rising investments, improved internet connectivity, and growing technological advancements.

For instance, in November 2024, the Canadian Space Agency, in partnership with Baune, introduced a telehealth station at the CLSC in Pierrefonds on Montreal's West Island that allows astronauts and patients to measure and monitor their pulse, blood pressure, and blood oxygen levels.

The section below outlines the key factors driving the growth of the global telehealth market, highlighting the increasing demand for remote healthcare services, rising prevalence of chronic diseases, growing internet and smartphone penetration, and expanding need for accessible healthcare across underserved and rural populations in the region. It also examines supportive government initiatives for digital health adoption, increasing investments in healthcare IT infrastructure, growing acceptance of virtual consultations and remote patient monitoring, and the rising presence of global and regional telehealth platform providers supporting market expansion.

Global Telehealth Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global telehealth report on the basis of product type, delivery mode, end use, disease area, and region:

• Product Type Outlook (Revenue, USD Billion, 2021 - 2033)
• Hardware
  • Monitors
  • Medical Peripheral Devices
  • Blood Pressure Meters
  • Blood Glucose Meters
  • Weighing Scales
  • Pulse Oximeters
  • Peak Flow Meters
  • ECG Monitors
  • Others
• Software
  • Standalone Software
  • Integrated Software
• Services
  • Remote Patient Monitoring
  • Real-Time Interactions
  • Store and Forward
  • Others
• Delivery Mode Outlook (Revenue, USD Billion, 2021 - 2033)
• On-premises
• Web-based
• Cloud-based
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Payers
• Providers
• Patients
• Disease Area Outlook (Revenue, USD Billion, 2021 - 2033)
• Psychiatry
• Substance Use
• Radiology
• Endocrinology
• Dermatology
• Gastroenterology
• Neurological Medicine
• ENT
• Cardiology
• Oncology
• Dental
• Gynecology
• General Medicine
• Others
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
  • Chile
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and scope

• 1.1. Market segmentation & scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research methodology
• 1.3. Information procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or data analysis
  • 1.4.1. Data analysis models
• 1.5. Market formulation & validation
• 1.6. Model details
  • 1.6.1. Multi-lens modeling framework (model 1)
  • 1.6.2. Commodity flow analysis (model 2)
  • 1.6.3. Regional & country-level estimation
  • 1.6.4. Segment level market size estimates - top-down
  • 1.6.5. Segment share calculation
  • 1.6.6. CAGR estimation and forecast factors
• 1.7. Research assumptions
• 1.8. List of secondary sources
• 1.9. List of primary sources

Chapter 2. Executive summary

• 2.1. Market outlook
• 2.2. Segment outlook
  • 2.2.1. Product outlook
  • 2.2.2. Delivery mode outlook
  • 2.2.3. Disease area outlook
  • 2.2.4. End use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive insights

Chapter 3. Telehealth market variables, trends & scope

• 3.1. Market lineage outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing adoption of digital health technologies
    • 3.2.1.2. Shortage of medical professionals and increasing demand for healthcare services
    • 3.2.1.3. High penetration of smartphones
    • 3.2.1.4. Expanding integration with wearable devices and electronic health records
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Cybersecurity and privacy concerns
    • 3.2.2.2. Lack of healthcare infrastructure in developing regions
• 3.3. Telehealth: market analysis tools
  • 3.3.1. Industry analysis - Porter's Five Forces Analysis
  • 3.3.2. Pestle analysis
• 3.4. Telehealth adoption rate (%)
• 3.5. Technology landscape
• 3.6. Funding scenario
• 3.7. Case study analysis
• 3.8. Use Case 1: Tele-Psychiatry for mental health support in chronic disease patients
• 3.9. Use Case 2: Telemedicine for diabetes management (remote glycemic monitoring program)
• 3.10. Use Case 3: AI-enabled remote monitoring for cardiac risk management
• 3.11. Use Case 4: Remote COPD care and digital pulmonary rehabilitation
• 3.12. Integration Trends Between Telehealth and Pharma
• 3.13. Regulatory And Reimbursement Shifts Impacting Remote Prescribing And Therapy Adherence Solutions
• 3.14. Key evaluation matrix, by key 40 companies 2021 - 2031
  • 3.14.1. Monthly active users
    • 3.14.1.1. Leaders
    • 3.14.1.2. Challengers
    • 3.14.1.3. Innovators
    • 3.14.1.4. Emerging players
  • 3.14.2. Paid users
    • 3.14.2.1. Leaders
    • 3.14.2.2. Challengers
    • 3.14.2.3. Innovators
    • 3.14.2.4. Emerging players

Chapter 4. Telehealth market segment analysis, by product, 2021 - 2033 (USD Billion)

• 4.1. Definition and scope
• 4.2. Product market share analysis, 2025 & 2033
• 4.3. Segment dashboard
• 4.4. Global telehealth market, by product, 2021 to 2033
• 4.5. Hardware
  • 4.5.1. Hardware market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.5.2. Monitors
    • 4.5.2.1. Monitors market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.5.3. Medical peripheral devices
    • 4.5.3.1. Medical peripheral devices market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.2. Blood pressure meters
      • 4.5.3.2.1. Blood pressure meters market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.3. Blood glucose meters
      • 4.5.3.3.1. Blood glucose meters market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.4. Weighing scales
      • 4.5.3.4.1. Weighing scales market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.5. Pulse oximeters
      • 4.5.3.5.1. Pulse oximeters market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.6. Peak flow meters
      • 4.5.3.6.1. Peak flow meters market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.7. ECG monitors
      • 4.5.3.7.1. ECG monitors market estimates and forecasts, 2021 to 2033 (USD Billion)
    • 4.5.3.8. Others
      • 4.5.3.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)
• 4.6. Software
  • 4.6.1. Software market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.6.2. Standalone software
    • 4.6.2.1. Standalone software market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.6.3. Integrated software
    • 4.6.3.1. Integrated software market estimates and forecasts, 2021 to 2033 (USD Billion)
• 4.7. Services
  • 4.7.1. Services market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.7.2. Remote patient monitoring
    • 4.7.2.1. Remote patient monitoring market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.7.3. Real-time interactions
    • 4.7.3.1. Real-time interactions market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.7.4. Store and forward
    • 4.7.4.1. Store and forward market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 4.7.5. Others
    • 4.7.5.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 5. Telehealth market segment analysis, by delivery mode, 2021 - 2033 (USD Billion)

• 5.1. Definition and scope
• 5.2. Delivery mode market share analysis, 2025 & 2033
• 5.3. Segment dashboard
• 5.4. Global telehealth market, by delivery mode, 2021 to 2033
• 5.5. On-premise
  • 5.5.1. On-premise market estimates and forecasts, 2021 to 2033 (USD Billion)
• 5.6. Web-based
  • 5.6.1. Web-based market estimates and forecasts, 2021 to 2033 (USD Billion)
• 5.7. Cloud-based
  • 5.7.1. Cloud-based market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 6. Telehealth market segment analysis, by disease area, 2021 - 2033 (USD Billion)

• 6.1. Definition and scope
• 6.2. Disease area market share analysis, 2025 & 2033
• 6.3. Segment dashboard
• 6.4. Global telehealth market, by disease area, 2021 to 2033
• 6.5. Psychiatry
  • 6.5.1. Psychiatry market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.6. Substance use
  • 6.6.1. Substance use market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.7. Radiology
  • 6.7.1. Radiology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.8. Endocrinology
  • 6.8.1. Endocrinology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.9. Dermatology
  • 6.9.1. Dermatology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.10. Gastroenterology
  • 6.10.1. Gastroenterology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.11. Neurological medicine
  • 6.11.1. Neurological medicine market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.12. ENT
  • 6.12.1. ENT market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.13. Radiology
  • 6.13.1. Radiology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.14. Cardiology
  • 6.14.1. Cardiology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.15. Oncology
  • 6.15.1. Oncology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.16. Dental
  • 6.16.1. Dental market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.17. Gynecology
  • 6.17.1. Gynecology market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.18. General medicine
  • 6.18.1. General medicine market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.19. Others
  • 6.19.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Telehealth market segment analysis, by end use, 2021 - 2033 (USD Billion)

• 7.1. Definition and scope
• 7.2. End use market share analysis, 2025 & 2033
• 7.3. Segment dashboard
• 7.4. Global telehealth market, by end use, 2021 to 2033
• 7.5. Payers
  • 7.5.1. Payers market estimates and forecasts, 2021 to 2033 (USD Billion)
• 7.6. Providers
  • 7.6.1. Providers market estimates and forecasts, 2021 to 2033 (USD Billion)
• 7.7. Patients
  • 7.7.1. Patients market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 8. Telehealth market segment analysis, by region, 2021 - 2033 (USD Billion)

• 8.1. Regional market share analysis, 2025 & 2033
• 8.2. Regional market dashboard
• 8.3. Regional market snapshot
• 8.4. Telehealth market share by region, 2025 & 2033:
• 8.5. North America
  • 8.5.1. North America telehealth market, 2021 - 2033 (USD Billion)
  • 8.5.2. U.S.
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory scenario
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. U.S. Telehealth market, 2021 - 2033 (USD Billion)
  • 8.5.3. Canada
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory scenario
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. Canada telehealth market, 2021 - 2033 (USD Billion)
  • 8.5.4. Mexico
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory scenario
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Mexico telehealth market, 2021 - 2033 (USD Billion)
• 8.6. Europe
  • 8.6.1. Europe telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.2. Uk
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory scenario
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. UK telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.3. Germany
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory scenario
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Germany telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.4. France
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Regulatory scenario
    • 8.6.4.3. Competitive scenario
    • 8.6.4.4. France telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.5. Italy
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Regulatory scenario
    • 8.6.5.3. Competitive scenario
    • 8.6.5.4. Italy telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.6. Spain
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Regulatory scenario
    • 8.6.6.3. Competitive scenario
    • 8.6.6.4. Spain telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.7. Norway
    • 8.6.7.1. Key country dynamics
    • 8.6.7.2. Regulatory scenario
    • 8.6.7.3. Competitive scenario
    • 8.6.7.4. Norway telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.8. Sweden
    • 8.6.8.1. Key country dynamics
    • 8.6.8.2. Regulatory scenario
    • 8.6.8.3. Competitive scenario
    • 8.6.8.4. Sweden telehealth market, 2021 - 2033 (USD Billion)
  • 8.6.9. Denmark
    • 8.6.9.1. Key country dynamics
    • 8.6.9.2. Regulatory scenario
    • 8.6.9.3. Competitive scenario
    • 8.6.9.4. Denmark telehealth market, 2021 - 2033 (USD Billion)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory scenario
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. Japan telehealth market, 2021 - 2033 (USD Billion)
  • 8.7.2. China
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory scenario
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. China telehealth market, 2021 - 2033 (USD Billion)
  • 8.7.3. India
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory scenario
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. India telehealth market, 2021 - 2033 (USD Billion)
  • 8.7.4. Australia
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory scenario
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Australia telehealth market, 2021 - 2033 (USD Billion)
  • 8.7.5. South Korea
    • 8.7.5.1. Key country dynamics
    • 8.7.5.2. Regulatory scenario
    • 8.7.5.3. Competitive scenario
    • 8.7.5.4. South Korea telehealth market, 2021 - 2033 (USD Billion)
  • 8.7.6. Thailand
    • 8.7.6.1. Key country dynamics
    • 8.7.6.2. Regulatory scenario
    • 8.7.6.3. Competitive scenario
    • 8.7.6.4. Thailand telehealth market, 2021 - 2033 (USD Billion)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Regulatory scenario
    • 8.8.1.3. Competitive scenario
    • 8.8.1.4. Brazil telehealth market, 2021 - 2033 (USD Billion)
  • 8.8.2. Argentina
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Regulatory scenario
    • 8.8.2.3. Competitive scenario
    • 8.8.2.4. Argentina telehealth market, 2021 - 2033 (USD Billion)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key country dynamics
    • 8.9.1.2. Regulatory scenario
    • 8.9.1.3. Competitive scenario
    • 8.9.1.4. South Africa telehealth market, 2021 - 2033 (USD Billion)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key country dynamics
    • 8.9.2.2. Regulatory scenario
    • 8.9.2.3. Competitive scenario
    • 8.9.2.4. Saudi Arabia telehealth market, 2021 - 2033 (USD Billion)
  • 8.9.3. UAE
    • 8.9.3.1. Key country dynamics
    • 8.9.3.2. Regulatory scenario
    • 8.9.3.3. Competitive scenario
    • 8.9.3.4. UAE telehealth market, 2021 - 2033 (USD Billion)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key country dynamics
    • 8.9.4.2. Regulatory scenario
    • 8.9.4.3. Competitive scenario
    • 8.9.4.4. Kuwait telehealth market, 2021 - 2033 (USD Billion)

Chapter 9. Competitive landscape

• 9.1. Recent developments & impact analysis, by key market participants
• 9.2. Company categorization
• 9.3. Company profiles
  • 9.3.1. Koninklijke Philips N.V.
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. GE Healthcare
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Oracle (Cerner Corporation)
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Siemens Healthineers AG
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Medtronic
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Teladoc Health, Inc.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. American Well
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Md Live
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Doctor On Demand
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Global Med
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives